juglone has been researched along with vitamin k 3 in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (11.11) | 18.2507 |
| 2000's | 7 (38.89) | 29.6817 |
| 2010's | 8 (44.44) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Divo, AA; Lin, TS; Sartorelli, AC; Xu, SP; Zhu, LY | 1 |
| Douglas, KT; Guedes, RC; Iley, J; Jaffar, M; Moreira, R; Valente, C | 1 |
| Carroll, PJ; DuHadaway, JB; Jaller, D; Kumar, S; LaLonde, JM; Malachowski, WP; Metz, R; Muller, AJ; Prendergast, GC | 1 |
| Cao, S; Foster, C; Kingston, DG; Lazo, JS; Murphy, BT | 1 |
| Kuramochi, K; Kuriyama, I; Maruo, S; Mizushina, Y; Tsubaki, K; Yoshida, H | 1 |
| Fischer, TC; Gosch, C; Gselmann, M; Mirbeth, B; Stich, K; Thallmair, V | 1 |
| Bhasin, D; Chettiar, SN; Etter, JP; Li, PK; Mok, M | 1 |
| Balaji, R; Dinesh, R; Kandhasamy, S; Karunagaran, D; Mathivanan, N; Mukesh, D; Perumal, PT; Shruthy, S; Shweta, S; Sreelatha, T | 1 |
| Bremer, PT; Hixon, MS; Janda, KD | 1 |
| Mostert, S; Petzer, A; Petzer, JP | 1 |
| Abdeen, S; Chapman, E; Chitre, S; Hoang, QQ; Johnson, SM; Park, Y; Ray, AM; Salim, N; Sivinski, J; Stevens, M; Washburn, A | 1 |
| Cui, J; Jia, J | 1 |
| Matthews, RS | 1 |
| Avila, J; Hernández, F; Martín, CP; Moreno, FJ; Santa-María, I | 1 |
| Cutler, HG; Cutler, SJ; Dawson, R; Graneli, E; Orano-Dawson, CE; Wright, DA | 1 |
| Cutler, HG; Cutler, SJ; Dawson, R; Orano-Dawson, CE; Wright, DA | 1 |
| Arnér, ES; Eriksson, SE; Flaberg, E; Prast-Nielsen, S; Szekely, L | 1 |
| Gautam, S; Kumar, S; Sharma, A | 1 |
18 other study(ies) available for juglone and vitamin k 3
| Article | Year |
|---|---|
Synthesis and antimalarial activity of 2-aziridinyl- and 2,3-bis(aziridinyl)-1,4-naphthoquinonyl sulfonate and acylate derivatives.
Topics: Animals; Antimalarials; Aziridines; Chemical Phenomena; Chemistry; Naphthoquinones; Plasmodium falciparum; Structure-Activity Relationship | 1991 |
The 1,4-naphthoquinone scaffold in the design of cysteine protease inhibitors.
Topics: Cathepsin B; Cysteine; Cysteine Proteinase Inhibitors; Models, Molecular; Molecular Structure; Naphthoquinones; Pancreatic Elastase; Papain | 2007 |
Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors.
Topics: Animals; Antineoplastic Agents; Binding Sites; Cell Proliferation; Cell Survival; Computer Simulation; Crystallography, X-Ray; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Mice, Knockout; Mice, Nude; Models, Molecular; Molecular Structure; Naphthoquinones; Pyrones; Stereoisomerism; Structure-Activity Relationship; Vitamin K 3 | 2008 |
Bioactivities of simplified adociaquinone B and naphthoquinone derivatives against Cdc25B, MKP-1, and MKP-3 phosphatases.
Topics: cdc25 Phosphatases; Cell Line, Tumor; Cell Proliferation; Cyclic S-Oxides; Dual Specificity Phosphatase 1; Dual Specificity Phosphatase 6; Enzyme Inhibitors; Humans; Magnetic Resonance Spectroscopy; Naphthoquinones; Spectrometry, Mass, Electrospray Ionization | 2009 |
Inhibitory effect of novel 5-O-acyl juglones on mammalian DNA polymerase activity, cancer cell growth and inflammatory response.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Cell Line, Tumor; DNA Polymerase beta; Enzyme Inhibitors; Humans; Inflammation; Lipopolysaccharides; Mice; Naphthoquinones; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 2011 |
Potent and specific bactericidal effect of juglone (5-hydroxy-1,4-naphthoquinone) on the fire blight pathogen Erwinia amylovora.
Topics: Agrochemicals; Anti-Bacterial Agents; Drug Evaluation, Preclinical; Drug Stability; Erwinia amylovora; Flowers; Germination; Hydrogen-Ion Concentration; Malus; Microbial Sensitivity Tests; Naphthoquinones; Plant Diseases; Quinones; Toxicity Tests | 2012 |
Anticancer activity and SAR studies of substituted 1,4-naphthoquinones.
Topics: Antineoplastic Agents; Cell Line, Tumor; Drug Screening Assays, Antitumor; HT29 Cells; Humans; Models, Molecular; Naphthoquinones; Structure-Activity Relationship | 2013 |
Synthesis and SAR study of novel anticancer and antimicrobial naphthoquinone amide derivatives.
Topics: Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Candida albicans; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Drug Screening Assays, Antitumor; Fluconazole; HeLa Cells; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Pseudomonas aeruginosa; Structure-Activity Relationship | 2014 |
Benzoquinones as inhibitors of botulinum neurotoxin serotype A.
Topics: Benzoquinones; Binding Sites; Botulinum Toxins, Type A; Drug Design; Kinetics; Molecular Docking Simulation; Protease Inhibitors; Protein Binding; Protein Structure, Tertiary; Structure-Activity Relationship | 2014 |
Evaluation of Natural and Synthetic 1,4-naphthoquinones as Inhibitors of Monoamine Oxidase.
Topics: Kinetics; Molecular Docking Simulation; Monoamine Oxidase Inhibitors; Naphthoquinones; Structure-Activity Relationship | 2016 |
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
Topics: Biological Products; Chaperonin 10; Chaperonin 60; Escherichia coli; Humans; Inhibitory Concentration 50; Protein Folding; Rafoxanide; Salicylanilides; Suramin | 2019 |
Discovery of juglone and its derivatives as potent SARS-CoV-2 main proteinase inhibitors.
Topics: Animals; Binding Sites; Catalytic Domain; Cell Survival; Chlorocebus aethiops; COVID-19; COVID-19 Drug Treatment; Drug Design; Drug Evaluation, Preclinical; Humans; Hydrogen Bonding; Molecular Docking Simulation; Naphthoquinones; Protease Inhibitors; SARS-CoV-2; Structure-Activity Relationship; Vero Cells; Viral Matrix Proteins | 2021 |
Artemia salina as a test organism for measuring superoxide-mediated toxicity.
Topics: Animals; Artemia; Biological Assay; Deferoxamine; Dimethyl Sulfoxide; Drug Evaluation, Preclinical; Drug Interactions; Hydrogen Peroxide; Naphthoquinones; Paraquat; Potassium Cyanide; Reactive Oxygen Species; Sensitivity and Specificity; Superoxide Dismutase; Superoxides; Ubiquinone; Vitamin K; Vitamin K 3 | 1995 |
Quinones facilitate the self-assembly of the phosphorylated tubulin binding region of tau into fibrillar polymers.
Topics: Amino Acid Motifs; Amino Acid Sequence; Benzoquinones; Cyclic AMP-Dependent Protein Kinases; Humans; Molecular Sequence Data; Naphthoquinones; Neurofibrillary Tangles; Peptide Fragments; Phosphorylation; Polymers; Protein Binding; Protein Processing, Post-Translational; Quinones; Recombinant Proteins; tau Proteins; Tubulin; Ubiquinone; Vitamin K 1; Vitamin K 3 | 2004 |
Naphthoquinones as broad spectrum biocides for treatment of ship's ballast water: toxicity to phytoplankton and bacteria.
Topics: Aliivibrio fischeri; Animals; Bacteria; Biological Assay; Dinoflagellida; Environmental Monitoring; Microscopy, Fluorescence; Naphthoquinones; Phytoplankton; Ships; Vitamin K 3; Waste Disposal, Fluid | 2007 |
Screening of natural product biocides for control of non-indigenous species.
Topics: Animals; Biological Products; Cyprinidae; Disinfectants; Invertebrates; Larva; Molecular Structure; Naphthoquinones; Pest Control; Phaeophyceae; Quinones; Ships; Toxicity Tests; Vitamin K 3 | 2007 |
High levels of thioredoxin reductase 1 modulate drug-specific cytotoxic efficacy.
Topics: Adenocarcinoma; Apoptosis; Auranofin; Cell Cycle; Cell Growth Processes; Cell Line, Tumor; Cisplatin; Dinitrochlorobenzene; Drug Resistance, Neoplasm; Humans; Lung Neoplasms; Naphthoquinones; RNA, Small Interfering; Thioredoxin Reductase 1; Vitamin K 3 | 2009 |
Antimutagenic and antioxidant properties of plumbagin and other naphthoquinones.
Topics: Anticoagulants; Antifibrinolytic Agents; Antimutagenic Agents; Antineoplastic Agents; Antioxidants; Drug Resistance, Bacterial; Escherichia coli; Molecular Structure; Naphthoquinones; Nucleic Acid Synthesis Inhibitors; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; Rifampin; Salmonella typhimurium; Structure-Activity Relationship; Vitamin K 3 | 2013 |